By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    benefits of using protein powder to build muscles
    Protein Powder for Muscle Mass: Everything You Need to Know
    December 12, 2021
    changes brought on by blockchain in healthcare
    Technology In The Healthcare Industry
    March 28, 2022
    What Does Core Body Temperature Say About Health?
    August 17, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    FDA Approves Diabetes Pill
    May 2, 2011
    Patient Gets Drunk on Hand Sanitizer
    June 20, 2011
    Cultivating Health Improvement
    July 20, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Stents for Stroke Prevention A Risky Proposition
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Cardiology > Stents for Stroke Prevention A Risky Proposition
BusinessCardiologyMedical DevicesNewsPublic Health

Stents for Stroke Prevention A Risky Proposition

gooznews
Last updated: January 27, 2012 9:34 am
gooznews
Share
7 Min Read
SHARE

Sen. Mark Kirk, Republican of Illinois, suffered a debilitating stroke on Monday, a tragedy for him and his family. Ironically, it occurred on the eve of one of the more important Medicare meetings of the year, which convened Wednesday at the Baltimore headquarters of the Center for Medicare and Medicaid Services to discuss the best ways to prevent strokes in at-risk older adults.

Sen. Mark Kirk, Republican of Illinois, suffered a debilitating stroke on Monday, a tragedy for him and his family. Ironically, it occurred on the eve of one of the more important Medicare meetings of the year, which convened Wednesday at the Baltimore headquarters of the Center for Medicare and Medicaid Services to discuss the best ways to prevent strokes in at-risk older adults.

Kirk, only 52, is reportedly asking for his Blackberry from his hospital bed, a good sign. He was stricken at an age when strokes are relatively rare and survival likely. But two-thirds of the 829,000 people who suffer strokes each year are over 65, and 85 percent of the 136,000 deaths each year from stroke are among that Medicare-eligible population.

No wonder that CMS, which pays the health care bills for the nation’s 45 million seniors, is concerned. The cost of treating the nearly half million Medicare beneficiaries who survive a stroke each year is staggering. It’s not just the hospitalizations, which can last a week or more, but the long-term rehabilitation and care. Many stroke victims are permanently disabled. Preventing strokes can be very cost-effective.

More Read

health savings account
Health Savings Accounts: Ten Years On
What You Need to Know About This Year’s AdvaMed Conference
Fast-Forward Scanning
Miseducation by Newspapers
A Von Eschenbach Sighting

Physicians have long wondered how to prevent strokes. Sometimes there are warning signs: slurred speech, or the sudden loss of eyesight in one eye. People with chronic hypertension and under high stress or who are obese are clearly at risk. Nearly a century ago, medical scientists noticed that strokes were often preceded by a narrowing of the carotid artery that feeds the brain. As imaging technologies evolved, it became possible to identify people with severe plaque build-up.

Technologies to reduce blockages soon followed. Drug treatment became possible with the development in the 1950s through 1980s of blood thinners and new drugs to lower blood pressure and cholesterol. Surgeons developed an operation to clean out that major artery called carotid endarterectomy.

And then, in the late 1990s and early in the last decade, the medical device industry developed carotid stents to prop open the crucial blood vessel leading to the brain. Though more expensive, physicians and hospitals increasingly used the procedure, and performed it on asymptomatic patients deemed at risk because of the plaque seen in imaging studies.

Now imagine you’re a person identified by your physicians as being seriously at risk of a stroke because of blockage in your carotid artery, even though you have no overt symptoms of disease. Which of these technologies, if any, should you use? While there isn’t clear cut medical evidence for you or your doctor, there are clear cut risks from the operations.

A technology assessment conducted by Blue Cross and Blue Shield for yesterday’s meeting showed the 30-day rate of deaths or strokes after the procedures (and thus considered procedure-related) were 6 percent for stenting and 3.2 percent for carotid endarterectomy in symptomatic patients, and 2.5 percent and 1.4. percent, respectively, in asymptomatic patients.  The assessment concluded that the risks outweighed the benefits for stenting in asymptomatic patients, and hadn’t proved it was as good as endarterectomy for either group.

That’s not what people thought a half decade ago. Pushed by manufacturers like Abbott, Boston Scientific and Medtronic and intervention cardiologists, Medicare approved payment for the stenting procedure in 2004 despite the absence of solid clinical trial evidence. Use quadrupled in the next two years to more than a thousand operations a month as its use expanded to asymptomatic patients.

Meanwhile, the use of the older and less expensive carotid endarterectomy procedure declined, at great cost to Medicare. A study that will be presented at Wednesday’s meeting by the Society for Vascular Surgery – they back endarterectomy, of course – claims the stent procedure costs $12,000 to $13,000 more “due to equipment and instrumentation.”

Stent manufacturers continued to push their favored approach at the meeting. The two procedures “have similar net outcomes, and they are comparable alternatives,” Charles Simonton, chief medical officer for Abbott Vascular, said in his written presentation, which was released earlier this week. He called for a “personalized approach” and expressed confidence that either procedure was “superior to best medical therapy (drugs) alone,” even though no clinical trial comparing the various approaches head-to-head has ever be done.

Despite the Blue Cross technology assessment, the advisory committee voted that there wasn’t enough evidence to provide a clear answer on what is the best treatment — surgery, stents, or medication — for Medicare patients with carotid plaque-buildup. That’s not what a recent editorial in the Archives of Internal Medicine said. Written by Seth Berkowitz and Rita Redberg of the University of California, San Francisco, the cardiologists raised serious concerns about the rapid increase in use of the pricey carotid artery stents.

Men over 70 fared worse with stenting, as did women in all age groups, they wrote.  Asymptomatic patients, who are at much less risk of having a stroke in the first place, shouldn’t get the operation at all given the heightened risk of stroke and death from the procedure. “Future trials may show that carotid stenting reduces the morbidity and mortality caused by cerebrovascular disease in asymptomatic patients,” Berkowitz and Redberg concluded. “Until then, however, carotid stenting . . . gets a ‘Less Is More’ designation because it has definite harms but unclear benefits.”

TAGGED:cardiac stentsstroke
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Dental health
May 21, 2025
The Secret To A Confident Smile: Top Tips For Better Teeth
The Secret To A Confident Smile: Top Tips For Better Teeth
Dental health
May 21, 2025
Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025

You Might also Like

Understanding the Patient Digital Search Process

March 27, 2015

Do-It-Yourself Death Panel

May 4, 2015

Medical Device Companies: Avoid These Inbound Marketing Mistakes

November 4, 2014

How do you know that your personal health data is secure in the cloud?

February 22, 2016
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?